
|Articles|March 29, 2021
Cytel Opens Solara to General Release & Launches New Trial Optimization Solution for Biotechs
Advertisement
Cytel announces that its clinical trial design and statistical software solution Solara is now available for general release to the pharma industry. Solara is available in two formats: standalone SaaS product, and as part of a consultancy solution. The consultancy solution is directed to smaller biopharma companies, which may lack an in-house biostatistician to lead the clinical trial design process.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
5



